Doris Hillemann Selected Research

Doris Hillemann Research Topics

10	Tuberculosis (Tuberculoses) 10/2023 - 06/2009
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2023 - 12/2007
3	Granuloma 01/2022 - 04/2010
2	Pulmonary Tuberculosis 10/2023 - 09/2010
2	Extensively Drug-Resistant Tuberculosis 01/2018 - 12/2007
1	Body Weight (Weight, Body) 09/2021
1	Infections 02/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018

7	Rifampin (Rifampicin)FDA LinkGeneric 10/2023 - 06/2009
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 12/2007
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 02/2020
3	AcidsIBA 02/2020 - 04/2010
2	Pyrazinamide FDA LinkGeneric 01/2022 - 01/2019
2	Clarithromycin (Biaxin)FDA LinkGeneric 09/2021 - 06/2020
2	Isoniazid (Ftivazide)FDA LinkGeneric 09/2021 - 06/2009
2	FluoroquinolonesIBA 09/2015 - 12/2007
1	Ertapenem (Invanz)FDA Link 10/2023
1	Meropenem (Merrem)FDA LinkGeneric 10/2023
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 10/2023
1	Clofazimine (Lamprene)FDA Link 01/2022
1	Capsules (Microcapsules)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Codon (Codons)IBA 01/2019
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2019
1	Nucleic AcidsIBA 01/2016
1	Coloring Agents (Dyes)IBA 04/2010
1	AminoglycosidesIBA 12/2007